Description: Joe Wurzburger, Staff Fellow at the SOA, shares some of his views and insights about the health care industry in general and the Health Section's role in particular.

Description: Joe Wurzburger, Staff Fellow at the SOA, shares his views and insights about the health care industry in general and the Health Section's role in particular.

Description: The big event of 2023 is the launch of multiple Humira biosimilars, which began in January with the arrival of Amgen’s Amjevita on the market. The launch of Amjevita kicks off the process of changing the specialty drug marketplace in the United States. The expectation of the full impact of this big event is very hopeful, but there is still uncertainty several months after its beginning. Humira is the highest-selling drug in the world and has been since 2013 (Figure 1)—except for when COVID-19 projects temporarily surpassed it. The world is eagerly awaiting the launch of multiple biosimilar drugs to compete with Humira and hopefully bring more competitive pricing to the benefit of payers and patients everywhere.

Description: Joe Wurzburger, Staff Fellow at the SOA, shares his views and insights about the health care industry in general and the Health Section's role in particular.

Description: This is a discussion of the paper, Gross Premiums for Individual and Family Major Medical Expense Insurance by Morton D. Miller. From Transactions of Society of Actuaries 1955, Vol. 7, No. 19.

Description: This article summarizes a report in the June 13, 1974 issue of the New England Journal of Medicine, Policy Options and The Impact of National Health Insurance which estimates the dollar and time price of various features common to many national health insurance proposals and the resulting effect on demand.

Description: Risk adjustment is used to adjust the revenue stream to health insurers that sell ACA eligible plans and Medicare Advantage plans. This article compares and contrasts these risk adjustment programs.

Description: Joe Wurzburger, Staff Fellow at the SOA, shares his views and insights about the health care industry in general and the Health Section's role in particular.

Description: This paper examines the 'King intervaluation method' within the framework of a health insurance valuation system. From Transactions of Society of Actuaries 1964, Vol. 16, Pt. 1, No. 45.